Kevork Peltekian

Dr. Kevork Peltekian is a renowned hepatologist and liver transplant expert with a strong background in medical education and patient care.

He obtained his medical degree from the American University of Beirut and completed postgraduate training in internal medicine, gastroenterology, and hepatology at prestigious institutions like Dalhousie University and the Toronto Hospital.

Dr. Peltekian has played a pivotal role in advancing liver disease research, education, and patient care in Atlantic Canada, serving as the only full-time hepatologist in the region until 2004.

He has held key leadership positions including Chairman and CEO of the Canadian Liver Foundation and President of the Canadian Association for the Study of Liver (CASL), where he significantly contributed to the growth and development of the organization.

His commitment to medical education and patient advocacy has been recognized through awards such as the Queen Elizabeth II Diamond Jubilee Medal and the Dr. Lea C. Steeves Award.

With a keen interest in public speaking, Dr. Peltekian is known for his engaging presentations on hepatology and liver transplantation, often incorporating humor to connect with his audience.

His research primarily focuses on fatty liver disease and hepatitis C infection among Atlantic Canadians, resulting in numerous high-impact peer-reviewed publications.

In addition to his medical expertise, Dr. Peltekian is an early adopter of technology, having implemented a web-based patient management system in his practice and actively engaging on social media platforms like Twitter.

His extensive professional experience includes roles such as Medical Director of the Liver Transplantation Team at the Atlantic Multi-Organ Transplantation Program and former President of Atlantic Hepatology Services Inc.

Dr. Peltekian has also held academic positions at Dalhousie University, where he served as an Associate Professor of Medicine & Surgery.